Ameriprise Financial Inc Surmodics Inc Transaction History

Ameriprise Financial Inc

$381 Billion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$27.44 - $35.56 $11,250 - $14,579	-410 Reduced 0.81%	50,395 $1.48 Million
Q4 2023 Feb 14, 2024	SELL	$28.47 - $38.49 $284 - $384	-10 Reduced 0.02%	50,805 $1.85 Million
Q3 2023 Nov 14, 2023	BUY	$28.28 - $38.36 $58,765 - $79,712	2,078 Added 4.26%	50,815 $1.63 Million
Q2 2023 Aug 14, 2023	BUY	$17.67 - $31.31 $113,618 - $201,323	6,430 Added 15.2%	48,737 $1.53 Million
Q1 2023 May 15, 2023	SELL	$17.13 - $38.52 $897,680 - $2.02 Million	-52,404 Reduced 55.33%	42,307 $963,000
Q4 2022 Feb 14, 2023	SELL	$29.44 - $37.31 $59,674 - $75,627	-2,027 Reduced 2.1%	94,711 $3.23 Million
Q3 2022 Nov 14, 2022	SELL	$28.84 - $38.92 $17,851 - $24,091	-619 Reduced 0.64%	96,738 $2.94 Million
Q2 2022 Aug 15, 2022	SELL	$33.25 - $45.11 $28,628 - $38,839	-861 Reduced 0.88%	97,357 $3.62 Million
Q1 2022 May 16, 2022	BUY	$40.68 - $49.72 $615,366 - $752,114	15,127 Added 18.21%	98,218 $4.45 Million
Q4 2021 Feb 14, 2022	BUY	$43.21 - $57.6 $605,156 - $806,688	14,005 Added 20.27%	83,091 $4 Million
Q3 2021 Nov 15, 2021	SELL	$52.8 - $60.32 $145,094 - $165,759	-2,748 Reduced 3.83%	69,086 $3.84 Million
Q2 2021 Aug 16, 2021	SELL	$51.29 - $59.15 $63,599 - $73,346	-1,240 Reduced 1.7%	71,834 $3.9 Million
Q1 2021 May 17, 2021	BUY	$42.18 - $56.07 $559,686 - $743,992	13,269 Added 22.19%	73,074 $4.1 Million
Q4 2020 Feb 12, 2021	SELL	$35.18 - $43.52 $82,813 - $102,446	-2,354 Reduced 3.79%	59,805 $2.6 Million
Q3 2020 Nov 16, 2020	SELL	$37.98 - $48.72 $38,359 - $49,207	-1,010 Reduced 1.6%	62,159 $2.42 Million
Q2 2020 Aug 14, 2020	SELL	$31.07 - $44.74 $83,733 - $120,574	-2,695 Reduced 4.09%	63,169 $2.73 Million
Q1 2020 May 15, 2020	SELL	$22.46 - $42.24 $87,077 - $163,764	-3,877 Reduced 5.56%	65,864 $2.19 Million
Q4 2019 Feb 14, 2020	SELL	$39.01 - $47.51 $93,624 - $114,024	-2,400 Reduced 3.33%	69,741 $2.89 Million
Q3 2019 Nov 14, 2019	SELL	$38.66 - $47.41 $1.27 Million - $1.56 Million	-32,865 Reduced 31.3%	72,141 $3.3 Million
Q2 2019 Aug 14, 2019	SELL	$38.23 - $47.43 $2.25 Million - $2.8 Million	-58,955 Reduced 35.96%	105,006 $4.53 Million
Q1 2019 May 15, 2019	BUY	$41.26 - $58.35 $346,212 - $489,614	8,391 Added 5.39%	163,961 $7.13 Million
Q4 2018 Feb 14, 2019	BUY	$44.93 - $73.38 $44,750 - $73,086	996 Added 0.64%	155,570 $7.35 Million
Q3 2018 Nov 14, 2018	BUY	$56.85 - $80.35 $1.59 Million - $2.25 Million	27,952 Added 22.08%	154,574 $11.5 Million
Q2 2018 Aug 14, 2018	BUY	$35.85 - $57.05 $2.03 Million - $3.23 Million	56,530 Added 80.65%	126,622 $6.99 Million
Q1 2018 May 15, 2018	BUY	$27.0 - $38.5 $61,533 - $87,741	2,279 Added 3.36%	70,092 $2.67 Million
Q4 2017 Feb 12, 2018	SELL	$28.0 - $33.2 $36,428 - $43,193	-1,301 Reduced 1.88%	67,813 $1.9 Million
Q3 2017 Nov 07, 2017	BUY	$24.5 - $31.1 $1.69 Million - $2.15 Million	69,114	69,114 $2.14 Million

Others Institutions Holding SRDX

# of Institutions

126

Shares Held

12M

Call Options Held

1.4K

Put Options Held

8.6K

Black Rock Inc. New York, NY

1.17M
Shares

$44.6 Million
0.0% of portfolio
Alliancebernstein L.P. New York, NY

1.04M
Shares

$39.6 Million
0.01% of portfolio
Beryl Capital Management LLC Redondo Beach, CA

989K
Shares

$37.7 Million
14.09% of portfolio
Vanguard Group Inc Valley Forge, PA

804K
Shares

$30.6 Million
0.0% of portfolio
Morgan Stanley New York, NY

753K
Shares

$28.7 Million
0.0% of portfolio

View Full List

About SURMODICS INC

Ticker SRDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,005,000
Market Cap $533M
Description
Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...

More about SRDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account